UKLG_PhD_BHF RevivR is a research project that is developing a new drug to treat heart failure. The project is led by Dr. Andrew Lane, a researcher at the University of Cambridge. The project is funded by the British Heart Foundation (BHF). The project is based on the idea that heart failure is caused by a build-up of fluid in the heart. The drug that the project is developing is designed to remove this fluid and improve the function of the heart. The project is in the early stages of development, but it has shown promising results in animal studies. The project is expected to complete human trials in the next few years. If successful, the drug developed by UKLG_PhD_BHF RevivR could revolutionize the treatment of heart failure. It could help millions of people around the world who suffer from this condition. Fun Facts UKLG_PhD_BHF RevivR is a collaboration between researchers at the University of Cambridge and the British Heart Foundation. The project is funded by a £10 million grant from the BHF. The project is in the early stages of development, but it has shown promising results in animal studies. The project is expected to complete human trials in the next few years. If successful, the drug developed by UKLG_PhD_BHF RevivR could revolutionize the treatment of heart failure.
show moreOutdoors
Outdoors
Outdoors
Outdoors
Outdoors
Outdoors
Outdoors
Outdoors
Outdoors
Buy one clothing item and get another at 50% off at bhf.org.uk.
Outdoors
Sign up for the newsletter and receive a special discount at bhf.org.uk.